According to Divis Laboratories's latest financial reports the company's current EPS (TTM) is โน73.52. In 2025 the company made an earnings per share (EPS) of โน84.09 an increase over its 2024 EPS that were of โน62.96.
Year | EPS | Change |
---|---|---|
2025 | โน84.09 | 33.56% |
2024 | โน62.96 | -13.53% |
2023 | โน72.81 | -43.09% |
2022 | โน127.93 | 43.87% |
2021 | โน88.92 | 48.34% |
2020 | โน59.94 | -6.22% |
2019 | โน63.91 | 44.63% |
2018 | โน44.19 | -17.61% |
2017 | โน53.64 | -3.78% |
2016 | โน55.75 | 24.33% |
2015 | โน44.84 | 6.03% |
2014 | โน42.28 | 16.24% |
2013 | โน36.38 | 5.7% |
2012 | โน34.42 | 8.37% |
2011 | โน31.76 | 24.59% |
2010 | โน25.49 | -8.08% |
2009 | โน27.73 | -5.19% |
2008 | โน29.25 | 100.08% |
2007 | โน14.62 | 177.51% |
2006 | โน5.27 |